|
Safety of using hormone replacement therapy in breast cancer survivors: A systematic review and metanalysis. |
|
|
No Relationships to Disclose |
|
|
Honoraria - Lilly; MSD Oncology; Novartis; Roche |
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Genomic Health; Ipsen; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen |
Travel, Accommodations, Expenses - Celgene; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Roche |
Speakers' Bureau - Lilly; Novartis; Pfizer; Roche; Sandoz; Takeda; Theramex |
|
|
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche; Takeda |
Other Relationship - Amgen; Novartis |